Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
2025-02-11Executive Order 14200
Signed by: Donald Trump
Presidential Documents
___________________________________________________________________
Title 3--
The President
Executive Order 14200 of February 5, 2025
Amendment to Duties Addressing the Synthetic
Opioid Supply Chain in the People's Republic of China
By the authority vested in me as President by the
Constitution and the laws of the United States of
America, including the International Emergency Economic
Powers Act (50 U.S.C. 1701 et seq.), the National
Emergencies Act (50 U.S.C. 1601 et seq.), section 604
of the Trade Act of 1974, as amended (19 U.S.C. 2483),
and section 301 of title 3, United States Code, I
hereby determine and order:
Section 1. Amendment. Regarding the Executive Order of
February 1, 2025 (Imposing Duties to Address the
Synthetic Opioid Supply Chain in the People's Republic
of China), the following shall replace subsection (g)
of section 2:
``(g) Duty-free de minimis treatment under 19
U.S.C. 1321 is available for otherwise eligible covered
articles described in subsection (a) of this section,
but shall cease to be available for such articles upon
notification by the Secretary of Commerce to the
President that adequate systems are in place to fully
and expediently process and collect tariff revenue
applicable pursuant to subsection (a) of this section
for covered articles otherwise eligible for de minimis
treatment.''
Sec. 2. General Provisions. (a) Nothing in this order
shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department, agency, or the
head thereof; or
(ii) the functions of the Director of the Office of Management and Budget
relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with
applicable law and subject to the availability of
appropriations.
(c) This order is not intended to, and does not,
create any right or benefit, substantive or procedural,
enforceable at law or in equity by any party against
the United States, its departments, agencies, or
entities, its officers, employees, or agents, or any
other person.
(Presidential Sig.)
THE WHITE HOUSE,
February 5, 2025.